Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday,...
ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.
1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present...
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received...
Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.